135 related articles for article (PubMed ID: 28911068)
21. Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
Martin P; Chadburn A; Christos P; Furman R; Ruan J; Joyce MA; Fusco E; Glynn P; Elstrom R; Niesvizky R; Feldman EJ; Shore TB; Schuster MW; Ely S; Knowles DM; Chen-Kiang S; Coleman M; Leonard JP
Ann Oncol; 2008 Jul; 19(7):1327-1330. PubMed ID: 18349031
[TBL] [Abstract][Full Text] [Related]
22. [Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma].
Vorobyev VI; Gemdzhian EG; Dubrovin EI; Nesterova ES; Kaplanov KD; Volodicheva EM; Zherebtsova VA; Kravchenko SK
Ter Arkh; 2019 Jul; 91(7):41-51. PubMed ID: 32598735
[TBL] [Abstract][Full Text] [Related]
23. Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases.
Veselá P; Tonar Z; Sálek D; Vokurka S; Trněný M; Kodet R; Moulis M; Kašparová P; Vernerová Z; Velenská Z; Stříteský J; Michal M; Boudová L
Virchows Arch; 2014 Nov; 465(5):587-97. PubMed ID: 25048573
[TBL] [Abstract][Full Text] [Related]
24. Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.
Trněný M; Lamy T; Walewski J; Belada D; Mayer J; Radford J; Jurczak W; Morschhauser F; Alexeeva J; Rule S; Afanasyev B; Kaplanov K; Thyss A; Kuzmin A; Voloshin S; Kuliczkowski K; Giza A; Milpied N; Stelitano C; Marks R; Trümper L; Biyukov T; Patturajan M; Bravo MC; Arcaini L;
Lancet Oncol; 2016 Mar; 17(3):319-331. PubMed ID: 26899778
[TBL] [Abstract][Full Text] [Related]
25. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
Cohen JB; Han X; Jemal A; Ward EM; Flowers CR
Cancer; 2016 Aug; 122(15):2356-63. PubMed ID: 27153197
[TBL] [Abstract][Full Text] [Related]
26. Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma.
Cohen JB; Ruppert AS; Heerema NA; Andritsos LA; Jones JA; Porcu P; Baiocchi R; Christian BA; Byrd JC; Flynn J; Penza S; Devine SM; Blum KA
Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):278-285.e1. PubMed ID: 25660723
[TBL] [Abstract][Full Text] [Related]
27. Is Limited-Stage Mantle Cell Lymphoma Curable and How Is It Best Managed?
Romancik JT; Cohen JB
Hematol Oncol Clin North Am; 2020 Oct; 34(5):849-859. PubMed ID: 32861282
[TBL] [Abstract][Full Text] [Related]
28. Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases.
Kim DH; Medeiros LJ; Aung PP; Young KH; Miranda RN; Ok CY
Am J Surg Pathol; 2019 Oct; 43(10):1421-1428. PubMed ID: 31219818
[TBL] [Abstract][Full Text] [Related]
29. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma.
Ning MS; Pinnix CC; Chapman BV; Gunther JR; Milgrom SA; Khoury JD; Jain P; Chen WY; Oriabure ON; Badillo MR; Wang LM; Dabaja BS
Blood Adv; 2019 Jul; 3(13):2035-2039. PubMed ID: 31289030
[TBL] [Abstract][Full Text] [Related]
30. TCL1 expression predicts overall survival in patients with mantle cell lymphoma.
Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J
Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients.
Haque W; Voong KR; Shihadeh F; Arzu I; Pinnix C; Mazloom A; Medeiros LJ; Romaguera J; Rodriguez A; Wang M; Allen P; Dabaja B
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):474-9. PubMed ID: 25108680
[TBL] [Abstract][Full Text] [Related]
32. Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases.
Tashakori M; Kim DH; Kanagal-Shamanna R; Vega F; Miranda RN; Jain P; Wang M; Medeiros LJ; Ok CY
Hum Pathol; 2021 Dec; 118():60-68. PubMed ID: 34655612
[TBL] [Abstract][Full Text] [Related]
33. Management Trends and Outcomes for Stage I to II Mantle Cell Lymphoma Using the National Cancer Data Base: Ascertaining the Ideal Treatment Paradigm.
Gill BS; Vargo JA; Pai SS; Balasubramani GK; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):668-76. PubMed ID: 26461009
[TBL] [Abstract][Full Text] [Related]
34. A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma.
Ng ZY; Bishton M; Ritchie D; Campbell R; Gilbertson M; Hill K; Ratnasingam S; Schwarer A; Manos K; Shorten S; Ng M; Nelson N; Xin L; De Mel Widanalage S; Sunny T; Purtill D; Poon M; Johnston A; Cochrane T; Lee HP; Hapgood G; Tam C; Opat S; Hawkes E; Seymour J; Cheah CY
Hematol Oncol; 2019 Aug; 37(3):253-260. PubMed ID: 30983008
[TBL] [Abstract][Full Text] [Related]
35. Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database.
Guru Murthy GS; Venkitachalam R; Mehta P
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S90-5. PubMed ID: 25486963
[TBL] [Abstract][Full Text] [Related]
36. Results from the Belgian mantle cell lymphoma registry.
Vergote V; Janssens A; André M; Bonnet C; Van Hende V; Van Den Neste E; Van Eygen K; Maerevoet M; Pranger D; Schroyens W; Debussche S; Maertens V; Beel K; Lemmens J; Caron C; Delrieu V; Van Den Broeck I; Vanstraelen G; Jacquy C; Schauvlieghe L; De Samblanx H; Madoe V; Meers S; Boulet D; Verhoef G; Van Hoof A
Acta Clin Belg; 2017 Jun; 72(3):172-178. PubMed ID: 28222652
[TBL] [Abstract][Full Text] [Related]
37. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.
Moding EJ; Advani R; Rosenberg SA; Hoppe RT
Radiother Oncol; 2018 Dec; 129(3):507-512. PubMed ID: 30539763
[TBL] [Abstract][Full Text] [Related]
39. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
40. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
